SCHEMBL9952589

SCHEMBL9952589

CC(Oc1ccc(-c2ccc(C(F)(F)F)cc2)cc1)c1ccc(C(=O)O)cn1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 1/20 0.46
PPARD Q03181 2/20 0.44
PTPN11 Q06124 1/20 0.44
RXRA P19793 1/20 0.42
RXRB P28702 1/20 0.42
RXRG P48443 1/20 0.42
SRD5A2 P31213 2/20 0.41
KMT2A Q03164 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
GRM4 Q14833 1/20 0.41
KIF11 P52732 1/20 0.41
PPARA Q07869 1/20 0.40
SLC6A2 P23975 1/20 0.40
P2RY14 Q15391 1/20 0.40
PTPN5 P54829 1/20 0.40
CYP2C8 P10632 1/20 0.40
MRGPRX4 Q96LA9 1/20 0.39
DHODH Q02127 1/20 0.39
RARB P10826 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9951071 0.85 GCGR (0.45) MAP4K4PPARDPTPN11SRD5A2L3MBTL1
SCHEMBL9951371 0.83 GCGR (0.56)
SCHEMBL14967355 0.81 GCK (0.48) RXRARXRBKMT2A
SCHEMBL9951173 0.75 LMNA (0.46) PPARDGRM4PPARA
SCHEMBL17219934 0.75 L3MBTL1 (0.57) RXRAL3MBTL1
SCHEMBL9950967 0.74 GCG (0.53) MAP4K4P2RY14
SCHEMBL14967482 0.73 ALDH1A1 (0.47) KMT2A
SCHEMBL2862455 0.72 LDHA (0.65) MAP4K4RXRARXRBRXRGSRD5A2
SCHEMBL7090499 0.71 LMNA (0.65) L3MBTL1
SCHEMBL2268771 0.71 PPARG (0.49) PPARDRXRARXRBRXRGSRD5A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150266861-A1 Glucagon Receptor Modulators PFIZER INC. (US) 2015-09-24 US disclosed
US-20150266861-A1 Glucagon Receptor Modulators PFIZER INC. (US) 2015-09-24 US disclosed
US-20150266861-A1 Glucagon Receptor Modulators PFIZER INC. (US) 2015-09-24 US disclosed
US-9056834-B2 Glucagon receptor modulators PFIZER INC. (US) 2015-06-16 US disclosed
US-9056834-B2 Glucagon receptor modulators PFIZER INC. (US) 2015-06-16 US disclosed
US-9056834-B2 Glucagon receptor modulators PFIZER INC. (US) 2015-06-16 US disclosed
US-20150094338-A1 Glucagon Receptor Modulators PFIZER INC. (US) 2015-04-02 US disclosed
US-20150094338-A1 Glucagon Receptor Modulators PFIZER INC. (US) 2015-04-02 US disclosed
US-20150094338-A1 Glucagon Receptor Modulators PFIZER INC. (US) 2015-04-02 US disclosed
US-8933104-B2 Glucagon receptor modulators PFIZER INC. (US) 2015-01-13 US disclosed
US-20140329862-A1 Glucagon Receptor Modulators PFIZER INC. (US) 2014-11-06 US disclosed
US-8809342-B2 Glucagon receptor modulators PFIZER INC. (US) 2014-08-19 US disclosed
US-8809342-B2 Glucagon receptor modulators PFIZER INC. (US) 2014-08-19 US disclosed
US-8809342-B2 Glucagon receptor modulators PFIZER INC. (US) 2014-08-19 US disclosed
EP-2655331-A1 GLUCAGON RECEPTOR MODULATORS Pfizer Inc (US) 2013-10-30 EP disclosed
WO-2012085745-A1 GLUCAGON RECEPTOR MODULATORS PFIZER INC. (US) 2012-06-28 WO disclosed
US-20120165343-A1 Glucagon Receptor Modulators PFIZER INC. (US) 2012-06-28 US disclosed
US-20120165343-A1 Glucagon Receptor Modulators PFIZER INC. (US) 2012-06-28 US disclosed
WO-2012085745-A1 GLUCAGON RECEPTOR MODULATORS PFIZER INC. (US) 2012-06-28 WO disclosed
US-20120165343-A1 Glucagon Receptor Modulators PFIZER INC. (US) 2012-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140329862-A1 Glucagon Receptor Modulators GLP1R, GCGR, GPR119 MAP4K4 365/4885PPARD 641/4885PTPN11 845/4885
US-20150094338-A1 Glucagon Receptor Modulators GLP1R, GCGR, GPR119 MAP4K4 365/4885PPARD 641/4885PTPN11 845/4885
US-20120165343-A1 Glucagon Receptor Modulators GLP1R, GCGR, GPR119 MAP4K4 365/4885PPARD 641/4885PTPN11 845/4885
US-20150266861-A1 Glucagon Receptor Modulators GLP1R, GCGR, GPR119 MAP4K4 365/4885PPARD 641/4885PTPN11 845/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.